This excerpt taken from the OSUR 8-K filed Nov 14, 2007.
SETTLE PATENT INFRINGEMENT LITIGATION
BETHLEHEM, PA., November 14, 2007 OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that an agreement has been reached on the principal terms to settle its pending patent infringement litigation against Schering-Plough Healthcare Products, Inc. (NYSE: SGP). The settlement is subject to completion and execution of a final settlement agreement.
Under the terms of the settlement, Schering-Plough will receive a license to OraSures patents in the U.S. OTC market and OraSure will receive payments of past and future royalties. We are pleased that a settlement has been reached in our pending litigation with Schering-Plough, said Douglas A. Michels, President and CEO of OraSure Technologies.
The litigation was commenced in 2004 when OraSure filed a lawsuit in the U.S. District Court for the Eastern District of Pennsylvania alleging that Schering-Ploughs manufacture and sale of its Dr. Scholls® Freeze Away® cryosurgical wart removal product in the U.S. over-the-counter market infringed several OraSure patents. Because an agreement on settlement terms has been reached, this matter was administratively dismissed by the District Court.